Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™[...]
09/13/2024 | Press release | Distributed by Public on 09/13/2024 11:40
Please select the service you want to use:
Smartlinks | ETF Opportunities Trust | Company News | Investment Funds | Private Companies | Exchange Traded Funds (ETF)
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact